Monte Rosa Therapeutics Inc (GLUE)

NASDAQ · Biotechnology

14.94
-0.44 (-2.86%)
Updated Aug 18, 6:42 PM ET
AI Rating
Strong Sell
Overall Score
24
Trend
28
Momentum
20
Risk
24

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Monte Rosa Therapeutics Inc is trading at $14.94, down 2.86% on the session. The 50 day average sits at $20.15 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 30.8, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $14.87 with resistance near $20.36, so that band frames the current range. Average daily movement is roughly $1.31, or about 8.8% of the share price, which is what any stop placement has to allow for. The overall health score of 24 out of 100 combines a trend score of 28, momentum of 20 and a risk score of 24.

Technical indicators

RSI (14)
30.8
weak
MACD
-1.745
bearish crossover
SMA 20
18.98
SMA 50
20.15
SMA 200
--
unknown
ATR (14)
1.31
avg daily range
Support
14.87
Resistance
20.36
Volume vs 20d
0.34x
below average
Volatility
118.4%
annualised
1 month
-33.07%
3 months
-17.02%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.